Startups
CamAPS® FX:
The advanced, adaptive, hybrid closed-loop app that automatically adjusts insulin delivery via an insulin pump based on sensor glucose readings.
Suitable from 1 years of age, including pregnancy, for use in people living with type 1 diabetes.
The advanced, adaptive, hybrid closed-loop app that automatically adjusts insulin delivery via an insulin pump based on sensor glucose readings.
Suitable from 1 years of age, including pregnancy, for use in people living with type 1 diabetes.
Overview
Employees
1-10
Founded date
2018
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 25, 2022 | Google Blocks NHS-Recommended App for Children With Diabetes | Thea Felicity, Tech Times 25 July 2022, 09:07 pm Google has reportedly refused to allow an NHS-recommended app for treating Type 1 diabetes to deliver text message notifications to the parents of young children who use it. (Photo : Towfiqu ... |
| Mar 22, 2022 | Ypsomed partners with CamDiab on smartphone-based automated insulin delivery | [Image from Ypsomed]Ypsomed (SWX:YPSN) announced today that it partnered with CamDiab to collaborate on managing automated insulin delivery with a mobile app. The partnership aims to launch CamDiab’s CamAPS FX app for managing glucose level... |
Reviews 0
FAQ about CamDiab
When was CamDiab founded?
CamDiab was founded in 2018.
What has the press written about CamDiab?
Parsers VC has collected 3 articles mentioning CamDiab, among them “Google Blocks NHS-Recommended App for Children With Diabetes” (Jul 25, 2022) and “Ypsomed partners with CamDiab on smartphone-based automated insulin delivery” (Mar 22, 2022).
Is CamDiab still active?
Yes, CamDiab is active; its latest activity on Parsers VC dates from Jun 26, 2024.